VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹315 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹315 Cr |
Mar2024 | ₹280 Cr |
Mar2023 | ₹240 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹137 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹315 Cr | 12.61 | |
Mar2024 | ₹280 Cr | 16.58 | |
Mar2023 | ₹240 Cr | 29.66 | |
Mar2022 | ₹185 Cr | 35.66 | |
Mar2021 | ₹137 Cr | - |
Compare Net Current Assets of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹645.1 Cr | 0.5% | -12.6% | 36.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 0.5% |
-12.6% |
36.5% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses